Ligand Pharmaceuticals Inc (NASDAQ:LGND)

188.97
Delayed Data
As of 10:56am ET
 -0.45 / -0.24%
Today’s Change
107.65
Today|||52-Week Range
196.56
+38.00%
Year-to-Date

Today’s Trading

Previous close189.42
Today’s open189.08
Day’s range187.92 - 189.75
Volume26,368
Average volume (3 months)340,368
Market cap$3.9B
Data as of 10:56am ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+56.81%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+29.48%
P/E ratio88.4
Price/Sales22.79
Price/Book9.59

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-1.20-0.75%
PBHPrestige Brands Hold...+0.82+2.42%
MDCOMedicines Co+0.67+2.10%
ICPTIntercept Pharmaceut...+0.44+0.64%
Data as of 11:11am ET, 05/25/2018

Financials

Next reporting dateAugust 6, 2018
EPS forecast (this quarter)$0.96
Annual revenue (last year)$141.1M
Annual profit (last year)$12.6M
Net profit margin8.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts